FDA Extends Comment Period for Public Meeting on Alternative Approaches in Animal Drug Development

Summary

The Food and Drug Administration (FDA) is extending the comment period for a public meeting on incorporating alternative approaches in clinical investigations for new animal drugs. The meeting was originally scheduled to receive comments on the use of novel investigation designs, data from foreign countries, and real-world evidence in animal drug development.